This is a continuation of application Ser. No. 07/886,992, filed May 21, 1992, now abandoned.
This invention was made with government support under grant number CA-31798 awarded by the National Institutes of Health. The government has certain rights in the invention.
Entry |
---|
Aruffo and Seed, 1987, "Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system," Proc. Natl. Acad. Sci. USA 84:8573-8577. |
Mizushima and Nagata, 1990, "pEF-BOS, a powerful mammalian expression vector," Nucl. Acids Res. 18(17):5322. |
Sambrook and Gething, 1988, "Vectors for high level expression of proteins in mammalian cells," Focus 10(3):41-48. |
Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2d ed., Cold Spring Harbor Laboratory Press, New York, pp. 16.17-16.22, 16.69, and 16.73-16.81. |
Seed, 1987, "An LFA-3 cDNA encodes a phospholopid-linked membrane protein homologous to its receptor CD2," Nature 329:840-842. |
Seed and Aruffo, 1987, "Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure," Proc. Natl. Acad. Sci. USA 84:3365-3369. |
Simmons and Seed, 1988, "Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells," J. Immunol. 141:2797-2800. |
Wong et al., 1985, "Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins," Science 228:810-815. |
Yang et al., 1986, "Human IL-3 (multi-CSF): identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3," Cell 47:3-10. |
Chan, et al., 1992, Adhesion to vascular cell adhesion molecule 1 and fibronectin comparison of .alpha..sup.4 .beta..sub.1 (VLA-4) and .alpha..sup.4 .beta..sub.7 on the human B cell line JY, J. Biol. Chem. 267:8366-8370. |
Hemler, et al., 1987, Characterization of the cell surface heterodimer VLA-4 and related peptides, J. Biol. Chem. 262:11478-11485. |
Elices, et al., 1990, VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site, Cell 60:577-584. |
Shimizu, et al., 1990, Regulated expression and binding of three VLA (.beta.l) integrin receptors on T cells, Nature 345:250-253. |
Chan, et al., 1992, Distinct cellular functions mediated by different VLA integrin .alpha. subunit cytoplasmic domains, Cell 68:1051-1060. |
Staunton, et al., 1989, Functional cloning of ICAM-2, a cell adhesion ligand of LFA-1 homologous to ICAM-1, Nature 339:61-64. |
de Fougerolles, et al., 1991, Characterization of ICAM-2 and evidence for a third counter-receptor fo LFA-1, J. Exp. Med. 174:253-267. |
de Fougerolles and Springer, 1992, Intercellular adhesion molecule 3, a third adhesion counter receptor for lymphocyte function-associated molecule 1 on resting lymphocytes, J. Exp. Med. 175:185-190. |
Springer, 1990, Adhesion receptors of the immune system, Nature 346:425-433. |
Pober and Cotran, 1990, The role of endothelial cells in inflammation, Transplantation 50:537-544. |
Dustin and Springer, 1988, Lumphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells, J. Cell. Biol. 107:312-331. |
Schwartz et al., 1990, Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J. Clin. Invest. 85:2019-2022. |
Pober et al., 1986, Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137(6): 1893-1896. |
Kishimoto et al., 1989, The leukocyte integrins, Adv. Immunol. 46:149-182. |
Springer et al., 1987, The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: Cell adhesion receptors of the Immune System, Ann. Rev. Immunol. 5:223-252. |
Carlos et al., 1990, Membrane proteins involved in phagocyte adherence to endothelium, Immunol. Rev. 114:5-28. |
Osborn et al., 1989 Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes, Cell 59:1203-1211. |
Wellicome et al., 1990, A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide, J. Immunol. 144:2558-2565. |
Rice et al., 1990, Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes, J. Exp. Med. 171:1369-1374. |
Carlos, et al. 1990, Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells, Blood 76:965-970. |
Guan and Hynes, 1990, Lymphoid cells recognize alternatively spliced segment of fibronectin via the integrin receptor .alpha..sub.4 .beta..sub.1, Cell 60:53-61. |
Wayner et al., 1989 Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin, J. Cell Biol. 109:1321-1330. |
Hemler, 1990, VLA proteins in the integrin family: structures, functions, and their role on leukocytes, Ann. Rev. Immunol 8:365-400. |
Clayberger et al., 1987, Identification and characterization of two novel lymphocyte function-associated antigens L24 and L25. J. Immunol. 138(5):1510-1514. |
Miyake et al., 1991, Evidence for a role of the Integrin VLA-4 in lympho-hemopoiesis. J. Exp. Med. 173:599-607. |
Williams et al., 1991, Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352:438-441. |
Miyake et al., 1991, A VCAM-like adhesion molecule on murine bone marrow stromal cell mediates binding of lymphocyte precursors in culture. J. Cell. Biol. 114(3):557-565. |
Ryan et al., 1991, Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells, J. Clin. Invest 88:995-1004. |
Freeman et al., 1990, Adhesion of human B cells to germinal centers in vitro involves VLA-4 and INCAM-110. Science 249:1030-1033. |
Taichman et al., 1991, Tumor cell surface .alpha..sup.4 .beta..sub.1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell. Reg. 2:347-355. |
Rice and Bevilacqua, 1989, An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 246:1303-1306. |
Cybulsky and Gimbrone, 1991, Endothelial expression of a mononuclear leukocyte adhesion molecule during antherogenesis. Science 251:788-791. |
Briscoe et al., 1991, Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts, Transplantation 51:537-547. |
Cybulsky et al., 1991, Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM.sub.1 gene. Proc. Natl. Acad. Sci. USA. 88:7859-7863. |
Polte et al., 1990, Full length vascular cell adhesion molecule 1 (VCAM-1), Nucl. Acids. Res. 18:5901. |
Cybulsky et al., 1991, Alternative splicing of human VCAM-1 in activated vascular endothelium, Amer. J. of Path. 138:815-820. |
Hession et al., 1991, Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1), J. Biol. Chem. 266:6682-6685. |
Rothlein et al., 1986, A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol 137(4): 1270-1274. |
Makgoba et al., 1988, Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity, Eur. J. Immunol 18:637-640. |
Oppenheimer-Marks et al., 1991, Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes, J. Immunol 147(9):2913-2921. |
Anderson and Springer, 1987, Leukocyte adhesion deficiency: an inherited defet in the Mac-1, LFA-1, and p 150,95 glycoproteins, Ann. Rev. Med. 38:175-194. |
Graber et al., 1990, T cells bind to cytokine-activated endothelial cells via a novel, inducible sialoglycoprotein and endothelial leukocyte adhesion molecule-1. J. Immunol 145(3):819-830. |
Thornhill et al., 1991, Tumor necrosis factor combines with IL-4 or IFN-y to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and independent binding mechanisms. J. Immunol 146(2):592-598. |
Pulido et al., 1991, Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J. Biol. Chem. 266(16):10241-10245. |
Number | Date | Country | |
---|---|---|---|
Parent | 886992 | May 1992 |